These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 91267)
1. A new antigenic determinant on HBsAg. Geographic and subtype distribution and association with HBeAg and anti-HBe. Bastiaans MJ; Nath N; Mazzur S Vox Sang; 1979; 37(3):129-38. PubMed ID: 91267 [TBL] [Abstract][Full Text] [Related]
2. Confirmatory evidence for the association of hepatitis B surface antigen with antigenic determinants reactive with antibodies present in some anti-HBe-positive sera. Neurath AR; Strick N; Huang CY J Gen Virol; 1980 May; 48(1):53-61. PubMed ID: 6155434 [TBL] [Abstract][Full Text] [Related]
3. HBsAg subtypes among HBsAg carriers in Okinawa, Japan. Evidence of an important relationship in seroconversion from HBeAg to anti-HBe. Noguchi A; Hayashi J; Nakashima K; Hirata M; Ikematsu H; Kashiwagi S J Infect; 1994 Mar; 28(2):141-50. PubMed ID: 8034993 [TBL] [Abstract][Full Text] [Related]
4. Relationship of subtypes of hepatitis B surface antigen with e antigen and its corresponding antibody. Nath N; Fang CT; Ledman R; Mazzur S; Dodd RY J Infect Dis; 1978 Aug; 138(2):252-6. PubMed ID: 681801 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of HBeAg and anti-HBe among HBsAg carrier thai children. Pongpipat D; Suvatte V; Assateerawatts A J Med Assoc Thai; 1981 Nov; 64(11):562-7. PubMed ID: 7320671 [No Abstract] [Full Text] [Related]
6. Prevalence of HBeAg, anti-HBe and Dane particle-associated DNA polymerase activity in asymptomatic carriers of HBsAg. Zanetti A; Ferroni P; Bergamini F; Legnani F Ric Clin Lab; 1979; 9(1):35-9. PubMed ID: 493812 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to delta antigen in asymptomatic hepatitis B surface antigen-reactive blood donors in the United States and their association with other markers of hepatitis B virus. Nath N; Mushahwar IK; Fang CT; Berberian H; Dodd RY Am J Epidemiol; 1985 Aug; 122(2):218-25. PubMed ID: 4014206 [TBL] [Abstract][Full Text] [Related]
8. Quantitation of HBeAG and anti-HBe by RIA in sera of chronic HBsAG carriers and individuals with type B hepatitis. Arnold W; Hess G; Kawakami H; Meyer zum Büschenfelde KH Klin Wochenschr; 1981 Jun; 59(12):679-83. PubMed ID: 7253542 [TBL] [Abstract][Full Text] [Related]
9. Significance of antibody to hepatitis Be antigen (anti-HBe) in HBsAg-negative individuals. Hess G; Arnold W; Gahl GM; Vogl E; Meyer zum Büschenfelde KH Vox Sang; 1981 Feb; 40(2):95-8. PubMed ID: 7233888 [TBL] [Abstract][Full Text] [Related]
10. An electron microscopic demonstration of immune complexes of hepatitis B e-antigen using colloid gold as a marker. Stannard LM; Lennon M; Hodgkiss M; Smuts H J Med Virol; 1982; 9(3):165-75. PubMed ID: 7097254 [TBL] [Abstract][Full Text] [Related]
11. Anti-HBe and subtypes of HBsAg among asymptomatic HBsAg carriers. Ukkonen P; Koistinen V; Penttinen K Vox Sang; 1979; 36(2):109-14. PubMed ID: 462897 [TBL] [Abstract][Full Text] [Related]
12. Radioimmunoassay for detection of hepatitis B e antigen and its antibody. Results of clinical evaluation. Mushahwar IK; McGrath LC; Drnec J; Overby LR Am J Clin Pathol; 1981 Nov; 76(5):692-7. PubMed ID: 6170222 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B surface antigen (HBsAg) subtype-specific antibodies in persons vaccinated against hepatitis B. Jilg W; Delhoune C; Deinhardt F; Roumeliotou-Karayannis AJ; Papaevangelou GJ; Mushahwar IK; Overby LR J Med Virol; 1984; 13(2):171-8. PubMed ID: 6198457 [TBL] [Abstract][Full Text] [Related]
14. [Radioimmunological determination of HBeAg/anti-HBe in HBsAg-positive liver diseases and in "healthy" HBsAg carriers]. Arnold W; Hess G; Dormeyer HH; Gahl G; Hoffmann HG; Knolle J; Schönborn H Z Gastroenterol; 1979 Oct; 17(10):704-12. PubMed ID: 118595 [TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases]. Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666 [TBL] [Abstract][Full Text] [Related]
16. Relationship of HBsAg subtypes with HBeAg/anti-HBe status and chronic liver disease. Part I: Analysis of 1744 HBsAg carriers. Shiina S; Fujino H; Uta Y; Tagawa K; Unuma T; Yoneyama M; Ohmori T; Suzuki S; Kurita M; Ohashi Y Am J Gastroenterol; 1991 Jul; 86(7):866-71. PubMed ID: 2058629 [TBL] [Abstract][Full Text] [Related]
17. Significance of tests for HBeAg and anti-HBe in HBsAg positive blood donors. Dow BC; Macvarish I; Barr A; Crawford RJ; Mitchell R J Clin Pathol; 1980 Nov; 33(11):1106-9. PubMed ID: 7440758 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of HBeAg and anti-HBe in blood donors with HBs antigenemia. Sabău M; Demeter S Virologie; 1978; 29(3):209-12. PubMed ID: 99868 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B e antigen in volunteer and paid blood donors. Tabor E; Goldfield M; Black HC; Gerety RJ Transfusion; 1980; 20(2):192-8. PubMed ID: 6966088 [TBL] [Abstract][Full Text] [Related]
20. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B. Niermeijer P; Gips CH; Huizenga JR; van der Waart M; Schuurs A Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]